Capps Green Zomaya Award
The Capps Green Zomaya Award recognises work in medicinal or computational medicinal chemistry.
The Award was established by Celltech, GlaxoSmithKline, NicOx and Vernalis, and is now independently administered by the Biological and Medicinal Chemicals Sector (BMCS) of the RSC in conjunction with the Capps Green Zomaya Trust.
Dr James Crawford, Genentech and Dr Richard Ward, AstraZeneca
- Run biennially
- The winner receives £2000, a certificate and a medal
- The winner is invited to give the 'Capps Green Zomaya Memorial Lecture' at the East of England Medicinal Chemistry Symposium in April 2020
- The winner will be chosen by an independent panel of senior chemists, selected by the Committee of the RSC Biological and Medicinal Chemistry Sector (BMCS) and the Capps Green Zomaya Trust
Guidelines for Nominators
- Nominations open on 01 March 2019
- Nominations close on 31 October 2019
- Open to RSC members and non-members
- Open to both UK and International scientists
- Self-nominations are accepted
- Candidates must be 40 years old or below on 31 October 2019. The age specified is intended to guide nominators and selection panelists; appropriate consideration will be given to those who have taken career breaks or followed different study paths.
- When nominating recent Award and Prize winners, please remember that a person cannot be rewarded twice for substantially the same body of work
2004 - present
History of the Award
This Award was founded in 2002 in memory of the chemists Nigel Capps, Richard Green and Alex Zomaya to recognise outstanding contributions to medicinal or computational medicinal chemistry.
It is run by the RSC Biological and Medicinal Chemicals Sector (BMCS) in conjunction with the Capps Green Zomaya Trust.
Winners of the award are invited to give the Capps Green Zomaya Memorial lecture at the East of England Medicinal Chemistry Symposium held in April each year.